IL10 and prostate carcinoma: Kobayashi et al. showed that IL-10 levels and tumor differentiation were associated with lymph node, local and distant metastasis in prostate cancer, which may be related to the suppression of immune response by IL-10 through the inhibition of IL-12 and γ-interferon (IFN-γ) 25.